Related Experiment Video

Updated: Aug 8, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Completion rates of adjuvant chemotherapy for colon cancer: a historical perspective

Victor R Grann, Franco M Muggia

    Journal of the National Cancer Institute
    |May 4, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
    07:54

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

    Published on: October 25, 2011

    Related Experiment Videos

    Last Updated: Aug 8, 2026

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
    06:46

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

    Published on: September 27, 2024

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
    07:54

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

    Published on: October 25, 2011

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based study.

    Archives of gynecology and obstetrics·2020

    Oral Squamous Cell Carcinoma as a Complication of Treatment for Recurrent High-Grade Serous Cancer.

    The Laryngoscope·2019

    Decreasing Trends of Secondary Primary Colorectal Cancer among Women with Uterine Cancer: A Population-Based Analysis.

    Journal of clinical medicine·2019

    Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis.

    Gynecologic oncology·2019

    Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective study.

    Archives of gynecology and obstetrics·2019

    Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.

    Obstetrics and gynecology·2019

    A new microsimulation model of HPV natural history for comparison of novel cervical screening strategies.

    Journal of the National Cancer Institute·2026

    Advancing opportunities for collaboration between national cancer Institute-Designated cancer centers and native nations: Building of an indigenous cancer health department.

    Journal of the National Cancer Institute·2026

    The early-onset pancreatic cancer paradox: a systematic review and meta-analysis.

    Journal of the National Cancer Institute·2026

    A validated clinical calculator of a brain metastasis risk (BrMR) prediction model in stage I-III breast cancer patients.

    Journal of the National Cancer Institute·2026

    Clinical and lifetime natural history of oral cancer: implications for screening and surveillance.

    Journal of the National Cancer Institute·2026

    21-Gene recurrence score assay in pN2-3 Early-Stage breast cancer: a national cancer database study.

    Journal of the National Cancer Institute·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us